Pravastatin Sodium Tablet
Product Images NDC 43063-807

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pravastatin Sodium (NDC 43063-807). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063807 Label (43063807)

Label for PRAVASTATIN SODIUM USP 20 mg oral tablets by PD-Rx Pharmaceuticals, Inc. This label indicates a package of 30 tablets with NDC 43063-807-30. The label includes prescription information and a warning to keep out of reach of children, along with reorder number, lot number D19C64, and expiration date 09/2020.*

FDA Label Image

Pravastatin Figure 1 (Pravastatin Fig1)

A survival distribution plot showing the proportion of subjects without coronary heart disease death or nonfatal myocardial infarction over approximately 5 years since randomization. The graph compares two groups: placebo and pravastatin, with the pravastatin group demonstrating a higher survival proportion without events over time. Statistical significance is indicated by a logrank P value of 0.0001.*

FDA Label Image

Pravastatin Chemical Structure (Pravastatin Struct)

Chemical structure of pravastatin sodium, showing its molecular formula C23H35NaO7 and molecular weight 446.52.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.